Lifestance Health

LFST

Market cap $1.99B

LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

LifeStance Health Group, Inc. (NASDAQ:LFST ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 10:00 AM EDT Company Participants David Bourdon - CEO & Director Ryan McGroarty - CFO & Treasurer Conference Call Participants Craig Hettenbach - Morgan Stanley, Research Division Presentation Craig Hettenbach VP & Equity Analyst All right. Great. Good morning, everyone.

SCOTTSDALE, Ariz., Aug. 26, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 23r d Annual Morgan Stanley Global Healthcare Conference, which will be hosted in New York City, NY.

Director William Miller to Step Down SCOTTSDALE, Ariz. , Aug. 22, 2025 /PRNewswire/ -- LifeStance Health (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced the appointment of Sarah Personette, an accomplished customer experience, media and technology executive, to the company's board of directors, effective today.

LifeStance Health Group, Inc. (NASDAQ:LFST ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants David Patrick Bourdon - CEO & Director Monica Prokocki - Vice President of Investor Relations Ryan Bruce McGroarty - CFO & Treasurer Conference Call Participants Brian Gil Tanquilut - Jefferies LLC, Research Division Craig Matthew Hettenbach - Morgan Stanley, Research Division David Michael Larsen - BTIG, LLC, Research Division Jamie Aaron Perse - Goldman Sachs Group, Inc., Research Division Kevin Caliendo - UBS Investment Bank, Research Division Lisa Christine Gill - JPMorgan Chase & Co, Research Division Matthew Mardula - Unidentified Company Richard Collamer Close - Canaccord Genuity Corp., Research Division Steven Craig Dechert - KeyBanc Capital Markets Inc., Research Division Operator Hello, and welcome to the LifeStance Health Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Now I would like to turn the call over to Monica Prokocki.

LifeStance Health Group (LFST) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.06 per share a year ago.

LifeStance (LFST) Q2 Revenue Jumps 11%

SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, 2025.

LifeStance Survey Finds Money Stress Significantly Impacts Americans' Mental Health and Ability to Seek Care SCOTTSDALE, Ariz. , July 22, 2025 /PRNewswire/ -- A LifeStance Health survey released today reveals "stressflation" is affecting most Americans, with 83% reporting financial stress driven by inflation, mass layoffs, the rising cost of living and recession fears.

SCOTTSDALE, Ariz., July 17, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2025 earnings release before the market opens on Thursday, August 7, 2025.